| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Gregory M Sullivan is Chief Medical Officer at TNXP. Gregory M Sullivan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Gregory M Sullivan has 14 Form 4 filings on record from March 2017 to February 2026, all as Chief Medical Officer at Tonix Pharmaceuticals (TNXP), 2017–2026.
The 30 reported transactions were 26 option or other derivative awards, 2 open-market purchases, 1 other transaction and 1 stock award.
Counted by filing, the open-market trades come to 2 purchases worth about $60K and no sales.
The largest open-market purchase was 10,000 shares of TNXP at an average $3.96 on June 14, 2018, about $40K.